Rheumatology in the Age of COVID-19: HCQ Shortages Driven by Small, Nonrandomized Study
Commercial Insurers Extend Coverage for Telehealth Services
Old Drug, New Interest: COVID-19 Spurs Hydroxycholoroquine Supply Concerns for Rheumatic Disease Patients
COVID-19 Pandemic Leads Big Drugmakers to Hit Pause on Clinical Trials
Roche Gets FDA Nod for Trial to Test Arthritis Drug on COVID-19 Patients
ACR Urges Commercial Payers to Provide Relief from Prior Authorizations, Practice Disruptions
ACR Advocates Against Payer Mandates on Specialty Pharmacy Acquisition of In-Office Treatments